Chronic myeloid leukaemia is in principle a treatable malignancy but drug resistance is lowering survival. Recent drug discoveries have opened up new options for drug combinations, which is a concept used in other areas for preventing drug resistance. | The effects of combination treatments on drug resistance in chronic myeloid leukaemia An evaluation of the tyrosine kinase inhibitors axitinib and asciminib